Stampacchia Otello

CIK 000136171214 companies1204 GENEVA, V8

SEC Profile

Transactions

Companies

Filings

CIK

0001361712

Recent Transactions

50 trades

Exercise/Conversion
ImageneBio, Inc.$IMA
Stock Option (right to buy)
2025-07-25−17,520→ 0 total
Purchase
ImageneBio, Inc.$IMA
Common Stock
2025-07-25$29.90/sh+267,556→ 454,982 total
Exercise/Conversion
ImageneBio, Inc.$IMA
Common Stock
2025-07-25+379→ 379 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2024-06-07+17,520→ 17,520 total
Conversion
Lexeo Therapeutics, Inc.$LXEO
Series A convertible preferred stock
2023-11-07−14,999,999→ 0 total
Purchase
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2023-11-07$11.00/sh+454,545→ 2,157,623 total
Conversion
Lexeo Therapeutics, Inc.$LXEO
Series B convertible preferred stock
2023-11-07−2,615,533→ 0 total
Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2023-11-07+1,415,865→ 1,415,865 total
Conversion
Lexeo Therapeutics, Inc.$LXEO
Common Stock
2023-11-07+287,213→ 1,703,078 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2023-06-09+17,520→ 17,520 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2022-06-22+34,000→ 34,000 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2022-06-09+13,419→ 13,419 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2022-03-16$15.55/sh−38,762→ 4,673,380 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2022-03-16$15.31/sh−6,238→ 4,712,142 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2022-03-15$15.64/sh−45,000→ 4,718,380 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2022-03-14$15.42/sh−16,500→ 4,763,380 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Non-Qualified Stock Options
2022-03-14−16,500→ 16,500 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2022-03-14$9.78/sh+16,500→ 4,779,880 total
Award
ImageneBio, Inc.$IMA
Stock Option (Right to Buy)
2021-12-21+13,419→ 13,419 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-22$34.70/sh−10,162→ 4,763,380 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-19$34.80/sh−417→ 4,773,542 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-19$34.54/sh−34,845→ 4,773,959 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-18$33.50/sh−2,441→ 4,808,804 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-18$33.50/sh−2,441→ 4,808,804 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-16$33.50/sh−153→ 4,811,245 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-16$33.50/sh−153→ 4,811,245 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-15$33.66/sh−782→ 4,811,398 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-12$33.66/sh−23,235→ 4,812,180 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-11$33.61/sh−18,279→ 4,835,415 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-10$33.50/sh−11→ 4,853,694 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-09$33.73/sh−7,537→ 4,853,705 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-08$33.53/sh−3,817→ 4,861,242 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-05$33.50/sh−5,790→ 4,865,059 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-11-04$33.58/sh−25,225→ 4,870,849 total
Conversion
Theseus Pharmaceuticals, Inc.
Common Stock
2021-10-12+523,979→ 523,979 total
Purchase
Theseus Pharmaceuticals, Inc.
Common Stock
2021-10-12$16.00/sh+187,500→ 711,479 total
Conversion
Theseus Pharmaceuticals, Inc.
Series B Preferred Stock
2021-10-12−693,152→ 0 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-09-23$33.58/sh−12,171→ 4,896,074 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-09-17$32.88/sh−78,998→ 4,923,710 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-09-17$33.71/sh−15,465→ 4,908,245 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2021-09-16$32.55/sh−5,537→ 5,002,708 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2021-06-22+20,600→ 20,600 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-30$55.73/sh−2,855→ 2,068,913 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-30$55.04/sh−5,274→ 2,071,768 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-30$54.26/sh−1,358→ 2,077,042 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-29$53.37/sh−3,826→ 2,082,245 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-29$55.23/sh−1,114→ 2,078,400 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-29$54.51/sh−2,731→ 2,079,514 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-28$55.36/sh−1,376→ 2,088,061 total
Sale
Morphic Holding, Inc.
Common Stock
2021-04-28$55.96/sh−1,990→ 2,086,071 total

Companies

Recent Filings

Address

12, RUE DE LA COULOUVRENIERE

1204 GENEVA, V8

View on SEC.gov